FENU, SANDRO
 Distribuzione geografica
Continente #
EU - Europa 123.546
NA - Nord America 7.206
AS - Asia 2.321
SA - Sud America 476
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 133.590
Nazione #
IT - Italia 121.512
US - Stati Uniti d'America 7.125
CN - Cina 1.058
SG - Singapore 909
UA - Ucraina 700
BR - Brasile 414
SE - Svezia 386
DE - Germania 368
GB - Regno Unito 194
FI - Finlandia 169
VN - Vietnam 111
KR - Corea 90
FR - Francia 71
CA - Canada 55
RU - Federazione Russa 46
IN - India 32
BD - Bangladesh 21
AR - Argentina 20
BE - Belgio 17
EC - Ecuador 16
ES - Italia 16
PL - Polonia 15
MX - Messico 14
HK - Hong Kong 13
IQ - Iraq 10
IR - Iran 10
TR - Turchia 10
CO - Colombia 9
NL - Olanda 9
EU - Europa 8
ZA - Sudafrica 8
IE - Irlanda 7
MA - Marocco 7
ID - Indonesia 6
JP - Giappone 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
RO - Romania 5
VE - Venezuela 5
AU - Australia 4
EG - Egitto 4
IL - Israele 4
JM - Giamaica 4
PY - Paraguay 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BN - Brunei Darussalam 3
BO - Bolivia 3
CR - Costa Rica 3
LT - Lituania 3
NP - Nepal 3
PK - Pakistan 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CH - Svizzera 2
DZ - Algeria 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
NO - Norvegia 2
PA - Panama 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BW - Botswana 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
Totale 133.590
Città #
Cagliari 119.219
Uta 1.951
Fairfield 764
Woodbridge 711
Chandler 561
Ashburn 547
Houston 436
Singapore 413
Ann Arbor 406
Jacksonville 376
Boardman 372
Dallas 356
Wilmington 352
Seattle 308
Nyköping 272
Cambridge 248
Beijing 184
Dearborn 157
Nanjing 117
Santa Clara 101
Hefei 93
Seoul 88
Boston 87
Los Angeles 80
Shanghai 77
Buffalo 66
Helsinki 61
The Dalles 60
Milan 51
New York 50
Guangzhou 43
Ho Chi Minh City 43
San Diego 41
Shenyang 38
São Paulo 37
Toronto 34
Nanchang 32
Hebei 30
Redwood City 30
Changsha 27
Jiaxing 27
Hanoi 26
Norwalk 25
Verona 25
Tianjin 22
Mountain View 17
Brussels 16
London 15
Auburn Hills 14
Munich 14
Redondo Beach 14
Washington 14
Chicago 13
Hong Kong 13
Orange 13
Kunming 12
Upgant-schott 12
Zhengzhou 12
Brasília 11
Hangzhou 11
Ningbo 11
Augusta 10
Council Bluffs 10
Atlanta 9
Frankfurt am Main 9
Jinan 9
Rio de Janeiro 9
San Mateo 9
Curitiba 8
Guarulhos 8
Saint Petersburg 8
Ardabil 7
Juiz de Fora 7
Montreal 7
Rome 7
San Francisco 7
Sassari 7
Assèmini 6
Belo Horizonte 6
Casalecchio di Reno 6
Düsseldorf 6
Mumbai 6
Naples 6
Renton 6
Salvador 6
Taizhou 6
Tashkent 6
Walnut 6
Wuhan 6
Biên Hòa 5
Brooklyn 5
Campinas 5
Columbus 5
Guayaquil 5
Marília 5
Modrice 5
Poplar 5
Santo André 5
Secaucus 5
Sorocaba 5
Totale 129.514
Nome #
Acquisition and expression of conditioned taste aversion differentially affects extracellular signal regulated kinase and glutamate receptor phosphorylation in rat prefrontal cortex and nucleus accumbens 4.560
null 4.110
Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation 4.008
Caffeine and the brain: an overview 3.675
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.592
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 3.395
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats 3.350
Behavioural pharmacology of caffeine 3.170
Evaluation of rewarding properties of pramipexole in a rat model of Parkinson’s disease: role of genetic background 3.064
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function 2.908
Behavioral Pharmacology of Caffeine 2.772
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: behavioral and biochemical study 2.696
L dopa chronic treatment increases reactive microglia and tnf- alpha production in the 6-ohda lesioned striatum 2.672
In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors 2.638
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: a behavioral and biochemical study 2.527
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2.448
Adolescent Cannabis exposure differentially affects heroin reinforcement and accumbens dopamine transmission in Lewis and Fischer344 rats 2.435
Possibile ruolo dei recettori 5-HT6 nelle dipendenze 2.225
null 2.160
null 2.148
Conditioned Saccharine Avoidance induced by intra-Accumbens shell amphetamine and intra-VTA morphine 2.114
Conditioned Saccharine Avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area 2.094
Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement 2.079
Influence of strain and age on voluntarily ethanol intake and on GAD-67 expression in the central amygdala 2.055
Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression 2.006
Possibile ruolo dei recettori 5-HT6 nelle dipendenze - Possible role of 5-HT6 receptors in addictions 1.972
null 1.797
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.746
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain 1.722
Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 1.710
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age 1.592
null 1.580
Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulant? 1.570
REINFORCING, REWARDING AND DOPAMINE-STIMULANT PROPERTIES OF THE 5-HT6 RECEPTOR AGONIST ST1936: THE FIST MEMBER OF A NEW CLASS OF PSYCHOSTIMULANTS? 1.547
Controversie: Priming dopaminergico nel Parkinson. Il "priming" come modello sperimentale delle discinesie indotte da terapie dopaminergiche sostitutive nella Malattia di Parkinson 1.499
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists 1.254
Effects of QO-IIR, a new COMT inhibitor, in experimental animal models of parkinson’s disease: behavioural, neurochemical and immunoistochemical study 1.234
Caffeine potentiates 3,4 methylenedioxymethamphetamine (MDMA, ecstasy)-induced-glial activation: role of age and adenosine A1 and A2A receptors 1.086
Differential involvement of dopamine D1 receptors in morphine- and lithium- conditioned saccharin avoidance 1.078
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease 1.003
Role of Adenosine A1 and A2A receptors on 3,4-methylendioxymeth-amphetamine (MDMA, Ecstasy)-induced neurotoxicity, astroglia and microglia reactivity in mouse striatum and substantia nigra 980
Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats 938
A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning 898
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 896
Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson’s disease 812
null 801
Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses 774
Modulation of dopamine d1-mediated turning behavior and striatal c-fos expression by the substantia nigra 759
Conditioned saccharin avoidance and sensitization to drugs of abuse 755
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 745
Accumbens shell dopamine and stimulus-reward learning 743
Effect of MK 801 on priming of D-1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen 741
“Priming” to dopamine agonist-induced contralateral turning as model of non associative sensitization to the expression of the post-synaptic dopamine message 719
Effetto del blocco dei recettori oppioidi delta sul turning controlaterale indotto dagli agonisti dopaminergici in ratti lesionati con la 6-idrossidopamina 706
Conditioned saccharin avoidance and sensitization to drugs of abuse 666
Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors 665
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 648
Dopamine and drug addiction: the nucleus accumbens shell connection 633
Blockade of pallidal adenosine A2A receptors potentiates contralateral rotational behavior induced by L-DOPA and dopaminergic agonists in hemiparkinsonian rats 631
Adenosine A2 Receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats 625
Changes in GAD67 and peptides mRNA levels in specific populations of striatal efferent neurons following priming with dopamine agonists in 6-OHDA lesioned rats 620
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 608
Different involvement of Dopamine D1 receptor in morphine and lithium conditioned saccharin avoidance 607
Alterazioni nei livelli striatali di RNAm della GAD67, dinorfina e enkefalina, in seguito a priming con agonisti dopaminergici nel modello di morbo di parkinson della 6-ohda 605
Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. 602
Effect of delta opioid receptors blockade on turning behavior induced by dopamine agonists in unilaterally 6-hydroxydopamine lesioned rats 601
Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of parkinsonism: role of priming 599
null 594
Differential effect of priming with dopamine agonists on mrna for GAD-67, dynorphin and enkephalin in 6-OHDA lesioned rats 590
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 587
null 580
Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors. 561
Different involvement of dopamine D1 receptor in morphine- and lithium-induced conditioned saccharin avoidance 553
‘Priming’ phenomena in the expression of D1 and D2 receptor supersensitivity 541
Differential role of dopamine in drug- and lithium conditioned saccharin avoidance 533
Opposite effects of nmda receptor blockade on dopaminergic d1-mediated and d2-mediated behavior in the 6-hydroxydopamine model of turning - relationship with c-fos expression 531
null 515
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 514
CONDITIONED TASTE AVERSION ELICITED ERK ACTIVATION AND CHANGES OF DENDRITIC SPINES DENSITY: AN IMMUNOHISTOCHEMICAL, GOLGI-COX AND ELECTRON MICROSCOPY STUDY 513
Modulation of turning behavior induced by dopamine D1 agonists in 6-hydroxydopamine lesioned rats by intranigral infusion of glutamate antagonists. 505
null 504
Opposite effects of NMDA receptor blockade on dopaminergic D1 and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression 488
null 479
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors 458
The influence of priming on the behavioral expression of dopamine receptor supersensitivity in basal ganglia 449
Nicotine-conditioned single–trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 432
null 425
Priming of the behavioral expression of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 420
Differential role of dopamine in drug- and lithium-conditioned saccharin avoidance 415
Priming of the behavioral of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 408
Blockade of NMDA receptors differentially affects D1 and D2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson 397
Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors 386
Motor stimulant effects of caffeine in 6-hydroxydopamine lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors 375
Facilitation of conditioned taste aversion learning by systemic amphetamine: role of nucleus accumbens shell dopamine D1 receptors 371
Dissociation of dopamine D1-induced turning behaviour and D1-induced increases in striatal acetylcholine release in 6-OHDA lesioned rats 363
Ruolo dell’acetilcolina striatale sul turning indotto dagli agonisti dopaminergici D1 in un modello sperimentale di morbo di parkinson: studio combinato microdialisi/comportamento. 351
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats 341
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 324
Disruption of latent inhibition in a conditioned taste aversion paradigm by D1 receptor blockade: role of dopamine in consolidation of gustatory memory traces 315
Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine 315
Totale 127.801
Categoria #
all - tutte 171.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.723 0 0 0 0 0 3.328 3.018 1.521 557 1.218 1.064 1.017
2021/20225.302 677 488 276 417 493 326 251 265 507 566 547 489
2022/20237.785 624 961 1.037 665 565 767 427 687 556 582 632 282
2023/202410.460 502 1.523 597 805 999 1.433 1.135 834 369 660 791 812
2024/202511.108 1.242 1.904 2.184 1.535 976 1.042 1.115 122 262 265 202 259
2025/20262.102 304 235 707 486 341 29 0 0 0 0 0 0
Totale 133.816